The Journal of thoracic and cardiovascular surgery
-
J. Thorac. Cardiovasc. Surg. · May 2023
Optimal circulatory arrest temperature for aortic hemiarch replacement with antegrade brain perfusion.
This study sought to identify the optimal temperature for moderate hypothermic circulatory arrest in patients undergoing elective hemiarch replacement with antegrade brain perfusion. ⋯ For patients with aneurysmal disease undergoing elective hemiarch with antegrade brain perfusion, circulatory arrest with a nadir temperature of 27°C confers the greatest early survival benefit and smallest risk of postoperative morbidity.
-
J. Thorac. Cardiovasc. Surg. · May 2023
Conduction mapping during complex congenital heart surgery: Creating a predictive model of conduction anatomy.
The study objectives were to report on a growing experience of conduction system mapping during complex congenital heart surgery and create a predictive model of conduction anatomy. ⋯ The precise anatomic location of the conduction system in patients with complex congenital heart defects can be difficult for the surgeon to accurately predict. Intraoperative conduction mapping enables localization of the His bundle and adds to our understanding of the anatomic factors associated with conduction location. Predictive modeling of conduction anatomy may build on what is already known about the conduction system and help surgeons to better anticipate conduction location preoperatively and intraoperatively.
-
J. Thorac. Cardiovasc. Surg. · May 2023
Assessing the impact of publications: A bibliometric analysis of the top-cited articles from The Journal of Thoracic and Cardiovascular Surgery.
After 90 years, The Journal of Thoracic and Cardiovascular Surgery (JTCVS) remains one of the most influential and widely read journals in our specialty. This study analyzes the characteristics of its top-cited articles over the past 6 decades. ⋯ JTCVS continues to provide a global platform to share impactful knowledge related to surgery for thoracic diseases. The use of citations to determine an article's impact has limitations and nontraditional metrics may prove to be an excellent complementary tool for more equitable evaluations.
-
J. Thorac. Cardiovasc. Surg. · May 2023
Clinicopathologic outcomes of preoperative targeted therapy in patients with clinical stage I to III non-small cell lung cancer.
Targeted therapy improves outcomes in patients with advanced-stage non-small cell lung cancer (NSCLC) and in the adjuvant setting, but data on its use before surgery are limited. We sought to investigate the safety and feasibility of preoperative targeted therapy in patients with operable NSCLC. ⋯ Preoperative targeted therapy was well tolerated and associated with good outcomes, with or without induction chemotherapy. In addition, radiographic response and pathologic response were strongly correlated.
-
J. Thorac. Cardiovasc. Surg. · May 2023
Aortic septotomy to optimize landing zones during thoracic endovascular aortic repair for chronic type B aortic dissection.
The role of thoracic endovascular aortic repair for chronic type B aortic dissection remains controversial. Clinical outcomes of thoracic endovascular aortic repair with recently implemented aortic septotomy strategy were compared with stand-alone thoracic endovascular aortic repair. ⋯ Stand-alone thoracic endovascular aortic repair outcomes without adjunctive procedures for chronic type B aortic dissection remain unfavorable. In contrast, landing zone optimization using aortic septotomy resulted in a remarkably higher positive aortic remodeling rate. Routine aortic septotomy strategy may positively affect long-term chronic type B aortic dissection survival and expand thoracic endovascular aortic repair candidacy.